Elevation Spine completed its Series B Preferred Stock financing, totaling $11 million.
Proceeds will support increased commercial production of Saber-C® spinal fusion technology, as well as development of future product extensions of the company’s Saber Technology platform of products.
Charles Gilbride, CEO of Elevation Spine, said, “This funding provides Elevation Spine with the capital to build out a full commercial team and expand the use of the Saber-C system. We will concurrently develop additional products utilizing Saber Technology to establish Saber as the leading platform technology in spinal fusions.”
Source: Elevation Spine
Elevation Spine completed its Series B Preferred Stock financing, totaling $11 million.
Proceeds will support increased commercial production of Saber-C® spinal fusion technology, as well as development of future product extensions of the company’s Saber Technology platform of products.
Charles Gilbride, CEO of Elevation Spine, said, “This...
Elevation Spine completed its Series B Preferred Stock financing, totaling $11 million.
Proceeds will support increased commercial production of Saber-C® spinal fusion technology, as well as development of future product extensions of the company’s Saber Technology platform of products.
Charles Gilbride, CEO of Elevation Spine, said, “This funding provides Elevation Spine with the capital to build out a full commercial team and expand the use of the Saber-C system. We will concurrently develop additional products utilizing Saber Technology to establish Saber as the leading platform technology in spinal fusions.”
Source: Elevation Spine
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.